Dokument: Detecting and understanding potential stigma among medical cannabis users in Germany
| Titel: | Detecting and understanding potential stigma among medical cannabis users in Germany | |||||||
| URL für Lesezeichen: | https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=69397 | |||||||
| URN (NBN): | urn:nbn:de:hbz:061-20250417-122147-4 | |||||||
| Kollektion: | Publikationen | |||||||
| Sprache: | Englisch | |||||||
| Dokumententyp: | Wissenschaftliche Texte » Artikel, Aufsatz | |||||||
| Medientyp: | Text | |||||||
| Autoren: | Borojevic, Velimir [Autor] Söhner, Felicitas [Autor] | |||||||
| Dateien: |
| |||||||
| Stichwörter: | Disclosure, Public health, Medical cannabis, Stigma, Quality of life | |||||||
| Beschreibung: | Background
Despite its increasing prevalence among the public, cannabis use is still perceived as deviant behavior and consequently stigmatized. However, there remains a paucity of understanding regarding the impact of this stigma on patients employing cannabis for therapeutic purposes. This qualitative research endeavored to explore the stigma experiences of medical cannabis (MC) users in Germany, aiming to discern challenges that may impede their daily lives and healthcare access. The primary objective of this study was to identify instances of stigma associated with MC usage across various spheres. Methods We conducted semistructured interviews with 15 individuals prescribed MC across diverse regions and occupational backgrounds in Germany. Interviews explored personal experiences with MC use, interactions with healthcare professionals, and stigma-related challenges. Data collection adhered to the COREQ guidelines. Transcribed interviews underwent systematic qualitative content analysis using MAXQDA software, with coding developed iteratively through researcher discussions. Communicative validation and inter-coder comparison enhanced analytical robustness. Results Despite participants exhibiting a positive attitude towards the therapeutic effects and benefits of MC, stereotypes and prejudices persist. Participants highlighted the role of media portrayals and a lack of public awareness as central barriers to broader societal acceptance. Personal experiences with MC were marked by improved quality of life but also internalised stigma and external challenges, including interactions with law enforcement and difficulties with healthcare access. Conclusion This qualitative study suggests that the utilisation of MC remains inadequately normalised in Germany. Our findings indicate that MC users experience both substantial benefits and persistent challenges, with stigma remaining a key issue. While participants reported improvements in quality of life, barriers such as bureaucratic hurdles and knowledge gaps among healthcare professionals hinder access to appropriate care. The findings underscore the imperative for enhanced education among healthcare professionals. | |||||||
| Rechtliche Vermerke: | Originalveröffentlichung:
Borojevic, V., & Söhner, F. (2025). Detecting and understanding potential stigma among medical cannabis users in Germany. BMC Public Health, 25, Article 874. https://doi.org/10.1186/s12889-025-22084-w | |||||||
| Lizenz: |  Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz | |||||||
| Fachbereich / Einrichtung: | Medizinische Fakultät | |||||||
| Dokument erstellt am: | 17.04.2025 | |||||||
| Dateien geändert am: | 17.04.2025 |
